Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02501356 · ClinicalTrials.gov registry record · NA
Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults
A NA study, sponsored by Griffin Hospital.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT02501356 is a NA study that has completed, run by Griffin Hospital. The registered enrollment target is 103 participants.
The verdict
NCT02501356, a NA study, has completed, sponsored by Griffin Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
To compare the effects of daily intake of the ISOThrive supplement vs. a placebo on the primary outcome measure of body weight and secondary outcome measures (hunger/satiety, health-related measures and self-reported quality of life) in a group of overweight but otherwise healthy adults.
Interventions
- DIETARY_SUPPLEMENT Placebo Supplement
- DIETARY_SUPPLEMENT ISOThrive Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02501356
The ClinicalTrials.gov registry entry for NCT02501356 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Griffin Hospital, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Supplement is the first listed.
NCT02501356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02501356 about?
NCT02501356 is a clinical study titled "Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults". To compare the effects of daily intake of the ISOThrive supplement vs. a placebo on the primary outcome measure of body weight and secondary outcome measures (hunger/satiety, health-related measures and self-reported quality of life) in a group of overweight but otherwise healthy adults.
What is the current status of trial NCT02501356?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2015-04. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02501356?
The interventions under investigation include: Placebo Supplement (DIETARY_SUPPLEMENT), ISOThrive Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02501356?
This trial is sponsored by Griffin Hospital, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.